Published date: 6 March 2023
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Business development consultancy services - 79411100
Location of contract
SE1 8UG
Value of contract
£90,000
Procurement reference
CF-1383400D0O000000rwimUAA
Published date
6 March 2023
Closing date
10 February 2023
Closing time
12pm
Contract start date
13 February 2023
Contract end date
31 March 2023
Contract type
Not applicable
Procedure type
Call-off from a framework agreement
A mini-competition or direct purchase from a pre-established framework agreement.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
Identifying the best approach for the NHS in relation to absorbing the cost impact of the
initial recommendations stemming from the NICE MTA undertaken for Type 1 Diabetes
hybrid closed-loop medical technology
More information
Attachments
-
- HSSF Order Form - BC 16165 Type 1 Diabetes Med-Tech Commercial Strategy (004) CF_Redacted.pdf
- HSSF Order Form - BC 16165 Type 1 Diabetes Med-Tech Commercial Strategy (004) CF_Redacted
Award information
Awarded date
24 February 2023
Contract start date
13 February 2023
Contract end date
31 March 2023
Total value of contract
£90,000
This contract was awarded to 1 supplier.
DELOITTE LLP
Address
1 New Street Square EC4A 3HQ
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Commercial Team
Address
Wellington House, 133-155 Waterloo Road
London
SE1 8UG
United Kingdom
Share this notice
Closing: 10 February 2023, 12pm